Bio stocks emerge as leading theme

Published: 2009-04-14 06:56:00

Updated: 2009-04-14 06:56:00

Bio-related stocks, including Diostech and Celltrion, have rallied as more foreigners are replacing institutional investors to lead the bullish trend of the tech-heavy Kosdaq.

According to FnGuide, an online financial information provider, yesterday, expatriates posted net sales of 565.7 billi...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK